Back to 
MORGAN STANLEY
MORGAN STANLEY
RARE9 quarters
Position history for MORGAN STANLEY's holdings in ULTRAGENYX PHARMACEUTICAL IN
MORGAN STANLEY holds 1.3M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $44.2M as of 2026-Q2. The position was decreased (-11.7% shares). RARE represents 0.0% of MORGAN STANLEY's portfolio.
Current Value
$44.2M
Current Shares
1.3M
Total Value Change
+$23.8M
Total Shares Change
+826,836
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors